Jibin Cao

Jibin Cao


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

25 May 2022 in Frontiers in Oncology
Verified
Journal Article
Open access
KZKexin Zhu
Kexin Zhu
ZCZhicheng Chen
Zhicheng Chen
LCLingling Cui
Lingling Cui
JZJinli Zhao
Jinli Zhao
YLYi Liu
Yi Liu
JCJibin Cao
Jibin Cao
Objective: Synthetic MRI (SyMRI) can reconstruct different contrast-weighted images(T1, T2, PD) and has shorter scan time, easier post-processing and better reproducibility. Some studies have shown splendid correlation with conventional mapping techniques and no degradation in the quality of syMRI images compared with conventional MRI. It is crucial to select an individualized treatment plan based on the preoperative images of rectal carcinoma (RC). We tried to explore the feasibility of syMRI on T, N stage and extramural vascular invasion (EMVI) of rectal cancer.Materials and Methods: A total of 100 patients (37 females and 63 males) diagnosed with rectal carcinoma were enrolled. All the patients underwent preoperative pelvic MR examinations including conventional MR sequence and synthetic MRI. Two radiologists evaluated the MRI findings of each rectal carcinoma and EMVI score in consensus. The values for T1, T2 relaxation times and PD value were measured in tumor(ROI-1) and pararectal fat space(ROI-2) and analyzed independently. A receiver operating characteristic (ROC) analysis was performed. Correlations between the T1, T2 and PD values and EMVI score were also evaluated.Results: Compared with the normal rectal wall, the values of T1 and T2 relaxation times of the tumor were significantly higher (P &lt;0.001). There was no statistically significant difference in the PD value (P >0.05). As for ROI, the ROI of pararectal fat space(ROI-2) had better significance than rectal cancer lesion (ROI-1). T2 value of ROI-1 and T1 value of ROI-2 were higher in the pEMVI positive group than in the negative group (P=0.002 and 0.001) and T1 value of ROI-2 had better performance with an AUC of 0.787, (95% CI:0.693- 0.882). T1 value, T2 value and PD value from ROI-2 were effective for both T and N stage of rectal cancer. High-grade pathological stage had showed higher T1 value (PT stage=0.013,PN stage=0.035), lower T2 value (PT stage=0.025,PN stage=0.034) and lower PD value (PT stage=0.017). We also enrolled the characteristics with P < 0.05 in the combined model which had better diagnostic efficacy. A significant positive correlation was found between the T1 value of pararectal fat space(ROI-2) and EMVI score (r value = 0.519, P<0.001). The T2 value(r=0.213,P=0.049) and PD value(r=0.354,P=0.001) from ROI-1 was correlated with EMVI score. Correlation analysis did not show any significant associations between T2 value of tumor, T2, PD values of pararectal fat space and EMVI scores.Conclusion: Synthetic MRI can provide multi-parameter quantitative image maps with a easier measurement and slightly shorter acquisition time compared with conventional MRI. The measurement of multi-parametric quantitative values contributes to diagnosing the tumor and evaluating T stage, N stage and EMVI. It has the potential to be used as a preoperative diagnostic and grading technique in rectal carcinoma.

3 March 2026 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
HZHao Zhang
Hao Zhang
RGRuisi Gong
Ruisi Gong
HFHefei Fu
Hefei Fu
JJJinlin Jiao
Jinlin Jiao
MLMengyao Li
Mengyao Li
LCLingling Cui
Lingling Cui
Background: Impaired glymphatic function is linked to cerebral atrophy and contributes to clinical disability in patients with relapsing-remitting multiple sclerosis (RRMS). Deep gray matter volume (DGMV) loss is associated with disability; however, its mediating effect in MS-related disability and glymphatic function changes remains underexplored. Methods: One hundred and thirty-one RRMS patients and 50 healthy controls (HC) underwent MRI scans. The DTI-ALPS index was used to evaluate glymphatic function. Z-scores of cortical and deep gray matter volumes (CGMV and DGMV) and WM-FA in RRMS patients were determined based on the mean and standard deviation of HC. RRMS patients were divided into two subgroups: the “MS-DGM-preserved” subgroup (z-scores of both CGMV, DGMV, and WM-FA > -2) and the “MS-DGM-atrophied” subgroup (z-scores of DGMV < -2) according to combinations of z-scores compared to HC. The mediating effect of DGMV in the relationship between the DTI-ALPS index and the clinical disability was further explored. Patients were followed up and had longitudinal outcomes. Results: Among all participants, 79 cases (60.3%) were classified as the MS-DGM-preserved subgroup, and 52 cases (39.7%) as the MS-DGM-atrophied subgroup. The MS-DGM-atrophied subgroup exhibited lower DTI-ALPS index (d=1.42, p-FDR< 0.001), higher T2-hyperintense white matter lesion volume (d=0.98, p-FDR< 0.001) and EDSS scores (d=0.49, p-FDR< 0.001), and longer disease duration (d=0.33, p-FDR=0.005) compared to the MS-DGM-preserved subgroup. Additionally, in the MS-DGM-atrophied subgroup, the DTI-ALPS index was significantly positively correlated with DGMV (r=0.59, p-FDR<0.001), and negatively correlated with EDSS scores and disease duration (r=-0.59, r=-0.56, p-FDR<0.001). Mediation analysis revealed that DGMV partially mediated the relationship between the DTI-ALPS index and clinical disability (EDSS and disease duration). In the longitudinal cohort, 18 MS patients were followed for a median time of 14 months (12.75, 14.00 months; range: 8–18 months). Compared to baseline, the DTI-ALPS index significantly decreased during follow-up (d=0.92, p-FDR=0.009). Conclusion: The RRMS subgroups based on the gradient classification of DGMV using structural MRI effectively distinguishes differences in glymphatic function and clinical disability. When DGM atrophy reaches a certain threshold, it partially mediates the relationship between glymphatic function and clinical disability.

13 March 2026 in Parkinsonism & Related Disorders
Verified
Journal Article
Closed access
ZRZhenghong Ren
Zhenghong Ren
LCLingling Cui
Lingling Cui
JCJibin Cao
Jibin Cao
GFguoguang Fan
guoguang Fan

10 February 2026 in Neurotherapeutics
Verified
Journal Article
Open access
JJJinlin Jiao
Jinlin Jiao
RGRuisi Gong
Ruisi Gong
HZHao Zhang
Hao Zhang
XHXu Huang
Xu Huang
LLLei Liu
Lei Liu
LCLingling Cui
Lingling Cui
The clinico-radiological paradox in multiple sclerosis (MS) describes the disconnect between white matter lesion load and clinical disability. This study investigated the role of deep gray matter (DGM) iron deposition in this paradox, specifically regarding cognitive impairment. We classified 134 MS patients into subgroups based on T2-lesion volume (LV) and disability (EDSS): LL/LD, HL/LD, LL/HD, HL/HD, comparing them to 46 healthy controls (HCs). Using quantitative susceptibility mapping (QSM) and volumetric analysis, we assessed iron content and atrophy in DGM nuclei, alongside cognitive testing (MoCA, SDMT). Subgroups with high lesion burden (HL/LD, HL/HD) showed significantly increased iron and atrophy in the globus pallidus, putamen, and caudate versus HCs. A critical group-by-volume interaction on susceptibility was found in the putamen for HL/LD (β=-0.55) and HL/HD (β=-0.35) subgroups. Mediation analysis revealed that putamen volume mediates the effect of iron on cognition, with significant indirect effects on SDMT (β=-0.18) and MoCA (β=-0.14) across all patients. In the HL/HD subgroup, this pathway accounted for 45.8 % of iron's total effect on processing speed (SDMT). Our findings demonstrate heterogeneous DGM iron deposition and identify putaminal iron-induced atrophy as a key mechanistic pathway for cognitive deficits, offering a novel explanation for the paradox and a potential biomarker for cognitive risk stratification.

1 June 2026 in Quantitative Imaging in Medicine and Surgery
Verified
Journal Article
Open access
PDF file
ZLZhengxin Liu
Zhengxin Liu
LCLingling Cui
Lingling Cui
FSFengyi Sun
Fengyi Sun
JZJiaxi Zhang
Jiaxi Zhang
YLYi Liu
Yi Liu
JCJibin Cao
Jibin Cao
Background: Preoperative evaluation of histopathological features and biomarkers is critical for personalized treatment of rectal adenocarcinoma. Amide proton transfer-weighted (APTw) magnetic resonance imaging (MRI) is a promising noninvasive functional imaging technique, but its predictive value in this tumor remains unclear. This study aimed to assess preoperative APTw MRI as a noninvasive imaging biomarker for predicting histopathological characteristics and biomarkers in rectal adenocarcinoma. Methods: This single-center prospective study enrolled 57 consecutive patients with biopsy-proven rectal adenocarcinoma who were treatment-naive and scheduled for radical surgery, between July 2020 and December 2021. Patients who had received neoadjuvant chemoradiotherapy were excluded to avoid confounding effects of treatment on tumor biology and imaging signal, thereby enabling a clear assessment of baseline APTw signal in relation to pathological features. All participants underwent preoperative APTw MRI and the mean intratumoral APTw signal intensity (APTw SImean) was quantitatively measured and correlated with key pathological parameters including tumor grade, lymph node (N) stage, extramural vascular invasion (EMVI), circumferential resection margin (CRM) and lateral pelvic lymph node metastasis (LPLNM), as well as immunohistochemical markers Ki-67 and p53. Diagnostic efficacy was quantitatively assessed via receiver operating characteristic (ROC) curve analysis, with corresponding area under the curve (AUC) values calculated. Results: Quantitative analysis revealed that APTw SImean was significantly higher in moderately differentiated (G2) versus well-differentiated (G1) tumors [mean difference: 0.523%, 95% confidence interval (CI): 0.248–0.798; P0.8) were observed for Ki-67 prediction and tumor grade. Conclusions: Preoperative APTw MRI is a noninvasive biomarker for predicting aggressive histopathological features in rectal adenocarcinoma. Quantitative APTw SImean is significantly associated with tumor grade, Ki-67 expression, and LPLNM presence.